Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden
Abstract
Authors
A Berglund A Ljungberg A Dorange
A Berglund A Ljungberg A Dorange
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now